Analyte monitoring device and methods of use
AssigneeAbbott Diabetes Care Inc.
InventorsThomas Peyser, Marc Taub, Susan Tall, Adam Heller
Life of this patent
Estimating the term…
Abstract
In one aspect, a housing comprising, a data processing unit, a data communication unit in communication with the data processing unit to communicate one or more signals related to an analyte level of a person of interest, and an insulin inhalation unit to deliver an inhalable dose of insulin, where the data processing unit is configured determine one or more discrete inhalable insulin dose amount based on the one or more signals related to the analyte level is provided.
Claims20
An integrated therapy management device, comprising:
- a housing comprising:
- a data processing unit;
- a data communication unit in communication with the data processing unit to communicate one or more signals related to an analyte level of a person of interest;
- and
- an insulin inhalation unit to deliver an inhalable dose of insulin;
- wherein the data processing unit is configured determine one or more discrete inhalable insulin dose amount based on the one or more signals related to the analyte level.
A post operative therapy management device, comprising:
- an analyte monitoring unit to monitor an analyte level of a person of interest substantially in real time during a post operative recovery period;
- and
- a drug administration unit operatively coupled to the analyte monitoring device to determine one or more medication dose amount based on the monitored analyte level of the person.
A method, comprising:
- monitoring substantially in real time an analyte level of a person of interest;
- and
- determining one or more discrete inhalable dose amount based on the substantially real time monitored analyte level of the person, wherein the analyte level is monitored during a post operative recovery period of the person.
Dependencies are inferred from the claim text.